Aspen Pharmacare
APNJSE · Healthcare · Market cap R72.0bn · 38th largest of the 141 JSE shares we screen
R166.39−0.47%
−R0.78 today · 17:00 SAST · delayed 15 minPrice
−0.47% today
Today, 5-minute prints, delayed 15 min · dotted: previous close R167.17
SENS announcements
Last 30 days · 4 announcements · 2 materialWhat Aspen Pharmacare has told the market through the JSE, newest first. Announcements that could move the share are marked Material.
- 5 Nov07:30Buy-backGeneral Repurchase of Ordinary Shares: Subsequent 3% RepurchaseBetween 2 November 2026 and 3 November 2026, Aspen repurchased a further 14,992,000 ordinary shares for R2,428,756,412.80 at an average price of R162.01 per share. The repurchased shares are expected to be delisted and cancelled before late November 2026.Not material
- 5 Nov07:05TransactionUpdate on the Divestment of a Womens Health Product in Europe to EnnogenThe divestment of commercialisation rights and related intellectual property for Ovestin in Europe to Ennogen Healthcare International Limited has completed. Aspen received the purchase consideration of EUR 197 million on 3 November 2026.Material
- 2 Nov10:30TransactionDivestment of a Womens Health Product in Europe to EnnogenAspen Global Incorporated is selling the European commercialisation rights and intellectual property for Ovestin to Ennogen for EUR 197 million plus inventory estimated at EUR 4 million, with proceeds planned for share buybacks.Material
- 23 Oct14:30Meeting noticeAvailability of Integrated Reporting Suite, B-BBEE Verification Certificate and Further Notice of Annual General MeetingThe 2026 Integrated Reporting Suite is available online, and the annual general meeting will be held on 3 December 2026, with a record date of 27 November 2026. The company also achieved a Level 4 B-BBEE contributor status.Not material
Free with an account. Click to preview what it shows.
The type, the Material marker and the summary are TradeIntel’s own reading of each announcement, written by software, not the company’s or the JSE’s.
Key numbers
screener, 6 NovMarket capR72.0bn
P/B0.91
Return on equity-1.1%
Dividend yield1.42%
1-year change+71.1%
52-week rangenow R166.39
R90.99R167.17
Our read on Aspen Pharmacare
Free with an account. Click to preview what it shows.
Also in Healthcare
todayJSE prices are delayed by at least 15 minutes. SENS announcements are published by the companies through the JSE’s Stock Exchange News Service; the type, the Material marker and the summary are TradeIntel’s own reading of each announcement, written by software.General information, not advice. TradeIntel is not a registered financial services provider.